Vitamin K with sorafenib showed anti-tumour effects in pancreas cancer

A combination of sorafenib and vitamin K had an effect in vitro on both human pancreas cancer and hepatocellular carcinoma, according to researchers from the Kimmel Cancer Centre at Jefferson. Data from the two studies were presented at the AACR 100th Annual Meeting 2009 in Denver...

Read the whole article on

More from